Get the Stockscreener App
0.7343
2.06%
0.0093
Assertio Holdings Inc stock is traded at $0.7343, with a volume of 103.90K.
It is up +2.06% in the last 24 hours and down -10.88% over the past month.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
See More
Previous Close:
$0.725
Open:
$0.72
24h Volume:
103.90K
Relative Volume:
0.27
Market Cap:
$70.68M
Revenue:
$169.43M
Net Income/Loss:
$-186.01M
P/E Ratio:
-0.3635
EPS:
-2.02
Net Cash Flow:
$70.07M
1W Performance:
-6.46%
1M Performance:
-10.88%
6M Performance:
+7.89%
1Y Performance:
-23.38%
1-Day Range:
$0.708
$0.74
1-Week Range:
$0.708
$0.7865
52-Week Range:
$0.5137
$1.0791
Assertio Holdings Inc Stock (ASRT) Company Profile
Name
Assertio Holdings Inc
Sector
Phone
(224) 419-7106
Address
100 S. SAUNDERS ROAD, LAKE FOREST, IL
Compare ASRT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASRT
Assertio Holdings Inc
|
0.7343 | 69.78M | 169.43M | -186.01M | 70.07M | -2.02 |
|
ZTS
Zoetis Inc
|
118.05 | 51.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.27 | 44.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.9025 | 42.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.14 | 27.86B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.73 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-26-24 | Initiated | Maxim Group | Buy |
| Jul-03-24 | Initiated | H.C. Wainwright | Buy |
| Nov-07-22 | Initiated | Lake Street | Buy |
| Nov-30-18 | Downgrade | Mizuho | Buy → Neutral |
Assertio Holdings Inc Stock (ASRT) Latest News
Can Assertio Holdings Inc. stock beat market expectations this quarterJuly 2025 Closing Moves & Advanced Swing Trade Entry Alerts - newser.com
Will Assertio Holdings Inc. stock attract ESG investorsNew Guidance & Real-Time Market Trend Scan - newser.com
Applying Elliott Wave Theory to Assertio Holdings Inc.2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
Is Assertio Holdings Inc. stock oversold or undervaluedPortfolio Value Report & Free Weekly Watchlist of Top Performers - newser.com
The growth track for Assertio Holdings Inc (ASRT) has changed recently - Setenews
Automated trading signals detected on Assertio Holdings Inc.2025 Volatility Report & Daily Profit Maximizing Tips - newser.com
Will Assertio Holdings Inc. stock benefit from AI adoptionMarket Activity Recap & Safe Entry Trade Reports - newser.com
How Assertio Holdings Inc. stock compares to market leadersJuly 2025 Setups & Detailed Earnings Play Strategies - newser.com
Using AI based signals to follow Assertio Holdings Inc.Quarterly Profit Review & Target Return Focused Stock Picks - newser.com
How to manage a losing position in Assertio Holdings Inc.Weekly Market Report & Weekly Consistent Profit Watchlists - newser.com
Visualizing Assertio Holdings Inc. stock with heatmapsFed Meeting & Daily Risk Controlled Trade Plans - newser.com
What does recent volatility data suggest for Assertio Holdings Inc.2025 Investor Takeaways & Community Consensus Picks - newser.com
Intraday pattern recognizer results for Assertio Holdings Inc.2025 Investor Takeaways & Daily Technical Stock Forecast Reports - newser.com
Will Assertio Holdings Inc. stock sustain high P E ratiosJuly 2025 Catalysts & Verified Momentum Stock Ideas - newser.com
Why Assertio Holdings Inc. stock is seen as undervaluedRisk Management & Weekly Stock Performance Updates - newser.com
Assertio Holdings, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates - Yahoo Finance
Assertio Holdings director Stark sells $6806 in shares By Investing.com - Investing.com Nigeria
Assertio Holdings director Stark sells $6806 in shares - Investing.com
An analyst sees good growth prospects for Assertio Holdings Inc (ASRT) - Setenews
Assertio Therapeutics Promotes Paul Schwichtenberg to President - MSN
Assertio Holdings, Inc. (NASDAQ:ASRT) Q3 2025 Earnings Call Transcript - Insider Monkey
Assertio Holdings Inc (ASRT) Q3 2025 Earnings Call Highlights: Impressive Growth Amid Market ... By GuruFocus - Investing.com Canada
Key metrics from Assertio Holdings Inc.’s quarterly dataJuly 2025 Trends & Weekly Market Pulse Alerts - newser.com
Earnings call transcript: assertio therapeutics beats Q3 2025 forecasts By Investing.com - Investing.com Nigeria
Assertio: Q3 Earnings Snapshot - CTPost
Assertio (ASRT) Surpasses Q3 Earnings and Revenue Estimates - sharewise.com
Assertio narrows 2025 guidance to $110M–$112M as Rolvedon pull-forward shapes cash flow outlook - MSN
Earnings call transcript: assertio therapeutics beats Q3 2025 forecasts - Investing.com India
Assertio Holdings Inc Stock (ASRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):